To determine the molecular mechanisms through which EGCG attenuates cardiac hypertrophy and myocardial fibrosis, we examined the involvement of the AKT/mTOR signalling pathway under pressure overload-induced injury. This evidence concerns the gene AKT1 and Myocardial fibrosis.